{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigl6zgd3jfwzrikzcloly6u3qmd3cwvzdak4lqahzunrbbn3zh26e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjpitktsvyx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif33blgrvy53okzlrjzskdymzc5qmxrtr3ln36lydfg3husva6aia"
    },
    "mimeType": "image/jpeg",
    "size": 161753
  },
  "path": "/news/2026-04-fda-access-peptides.html",
  "publishedAt": "2026-04-17T13:40:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.",
  "title": "FDA to review whether to allow more access to certain peptides"
}